Feds Crack Down On Fraud By Issuing New Medicaid Rules, Helping Medical Students Catch Fraud

Main Category: Medicare / Medicaid / SCHIP
Also Included In: Medical Students / Training
Article Date: 09 Nov 2010 – 5:00 PST

email to a friend   printer friendly   opinions  

Patient / Public:

Healthcare Prof:

Article Opinions: 0 posts

The Hill Healthwatch: “The Centers for Medicare and Medicaid Services on Friday proposed new rules for the use of private contractors that work for states to audit Medicaid payments. The Recovery Audit Contractors will function similarly to the way they do in the Medicare program, where they audit payments that may have been underpaid or overpaid, and recover overpayments or correct underpayments. … Under the new law, states must establish Medicaid RAC programs by submitting state plan amendments to CMS by December 31” (Pecquet, 11/5).

Seniors Need To Check Options As Medicare Advantage Plans Change, Drop Out

Main Category: Medicare / Medicaid / SCHIP
Also Included In: Seniors / Aging
Article Date: 09 Nov 2010 – 5:00 PST

email to a friend   printer friendly   opinions  

Patient / Public:

Healthcare Prof:

Article Opinions: 0 posts

CMS To Review Cancer Vaccine, Analysis Shows High Medicare Drug Spending Not Correlated With Better Care

Main Category: Medicare / Medicaid / SCHIP
Also Included In: Prostate / Prostate Cancer;  Immune System / Vaccines
Article Date: 09 Nov 2010 – 5:00 PST

email to a friend   printer friendly   opinions  

Patient / Public:

5 (1 votes)

Healthcare Prof:

Article Opinions: 0 posts

Medicare Policy Changes Will Make It More Difficult For Nevada Beneficiaries To Obtain Power Wheelchairs

Main Category: Medicare / Medicaid / SCHIP
Article Date: 09 Nov 2010 – 6:00 PST

email to a friend   printer friendly   opinions  

Patient / Public:

Healthcare Prof:

Article Opinions: 0 posts

Will power wheelchairs continue to be available to Nevada’s
Medicare patients following a series of federal regulatory and policy changes?

There are grave concerns among consumer groups, Medicare beneficiaries and homecare equipment
providers in Nevada that the changes in Medicare policies may severely hamper the ability of
providers to supply quality products and services to beneficiaries.

Today’s Op-Eds: The Medicare Cost-Cutting Debate; Two Perspectives On ‘Repeal And Replace’

Main Category: Medicare / Medicaid / SCHIP
Also Included In: Primary Care / General Practice;  Public Health;  Health Insurance / Medical Insurance
Article Date: 09 Nov 2010 – 6:00 PST

email to a friend   printer friendly   opinions  

Patient / Public:

Healthcare Prof:

Article Opinions: 0 posts

How Medicare Killed the Family Doctor The Wall Street Journal
Medicare introduced a whole new dynamic in the delivery of health care. Gone were the days when physicians were paid based on the value of their services. With payment coming directly from Medicare and the federal government, patients who used to pay the bill themselves no longer cared about the cost of services (Richard M. Hannon, 11/8).

Ban Tobacco Ads And Restrict Alcohol And Erectile Dysfunction Ads, Urges The American Academy Of Pediatrics

Editor’s Choice
Main Category: Pediatrics / Children’s Health
Also Included In: Smoking / Quit Smoking;  Alcohol / Addiction / Illegal Drugs;  Erectile Dysfunction / Premature Ejaculation
Article Date: 27 Sep 2010 – 9:00 PDT

email to a friend   printer friendly   opinions  

Patient / Public:

3.5 (2 votes)

Healthcare Prof:

5 (4 votes)

Article Opinions: 1 posts

The monumental task of persuading children and adolescents to say “No” to drugs, alcohol and tobacco is being constantly undermined by the $25 billions’ worth of advertising and marketing each year, which has precisely the opposite effect, says the American Academy of Pediatrics (AAP). The AAP adds that children should not be exposed to erectile dysfunction ads before ten at night.

Researchers Discover A Drug Combination That Shrinks Prostate Tumors In Vivo

 

Main Category: Prostate / Prostate Cancer
Also Included In: Cardiovascular / Cardiology;  Erectile Dysfunction / Premature Ejaculation
Article Date: 28 Sep 2010 – 3:00 PDT

email to a friend   printer friendly   opinions

Patient / Public:

4.33 (3 votes)

Healthcare Prof:

1 (1 votes)

Article Opinions: 0 posts
Virginia Commonwealth University School of Medicine and VCU Massey Cancer Center researchers have shown that the impotence drug Viagra, in combination with doxorubicin, a powerful anti-cancer drug, enhances its anti-tumor efficacy in prostate cancer while alleviating the damage to the heart at the same time.

Sexual Issues A Major Concern For Cancer Patients Taking New Targeted Drugs

Main Category: Cancer / Oncology
Also Included In: Sexual Health / STDs;  Erectile Dysfunction / Premature Ejaculation
Article Date: 13 Oct 2010 – 0:00 PDT

email to a friend   printer friendly   opinions  

Patient / Public:

5 (1 votes)

Healthcare Prof:

Article Opinions: 0 posts

New drugs that target specific molecular mechanisms of cancer have improved the treatment of cancer patients in recent years, but those benefits may come with a cost to the patient’s sex life, researchers have found.

NovaDel Pharma Inc. Announces Positive Data From Pilot Pharmacokinetic Study Comparing Duromist™ (Sildenafil Citrate Oral Spray) To Viagra(R)

 

Main Category: Erectile Dysfunction / Premature Ejaculation
Article Date: 20 Oct 2010 – 1:00 PDT

email to a friend   printer friendly   opinions

Patient / Public:

Healthcare Prof:

Article Opinions: 0 posts
NovaDel Pharma Inc. (OTCBB: NVDL), a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed pharmaceutical products, announced pharmacokinetic (PK) and safety results from its pilot PK study comparing Duromist™ to Viagra®. Duromist™ is NovaDel’s oral spray formulation of sildenafil citrate. Viagra® is the tablet formulation of sildenafil citrate developed and marketed by Pfizer. Sildenafil citrate is a leading drug indicated for the management of pulmonary hypertension and erectile dysfunction. NovaDel now plans to review the results from this study with the FDA to obtain guidance on defining definitive clinical trial requirements as a pathway to NDA approval.

Apricus Bio Announces First Patent Grant For Femprox(R) In Japan

Main Category: Erectile Dysfunction / Premature Ejaculation
Article Date: 20 Oct 2010 – 2:00 PDT

email to a friend   printer friendly   opinions  

Patient / Public:

Healthcare Prof:

Article Opinions: 0 posts

Apricus Biosciences, Inc., (“Apricus Bio”) (Nasdaq: APRI) backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline through out-licensing partnerships, today announced that the Japanese Patent Office has issued a Decision to Grant a Patent for the Company’s application on Femprox entitled, “Compositions and Methods for Amelioration of Human Female Sexual Dysfunction.” This patent, when issued, will provide Japanese patent protection to December 2019, and is one in a series of patents and pending applications that Apricus Bio owns on Femprox and the underlying NexACT technology.